General | Carbohydrate O/F | Substrate utilisation | Enzymes | Metabolites | Antibiotics

Overview


  • Kiritimatiella glycovorans is a Gram-negative, non-spore-forming, strictly anaerobic, non-motile, coccus bacterium. It has been detected in at least 1 gut microbiome compilation study or metastudy. The DNA G+C content is 63.3%. Kiritimatiella glycovorans is likely to be transient and not a long-term gut coloniser. (Spring2016)



  • This organism has been recovered from the suboxic zone of a hypersaline microbial mat, Republic of Kiribati. Pathogenicity status unknown, or very unlikely to be pathogenic. Likely to be transient and not a long-term gut commensal.

  • QUIRKS
  • Strictly fermentative and moderately halophilic. Borderline cold mesophile, with optimum growth temp of 28C. Unlikely gut coloniser.

  • GENERAL CHARACTERISTICS (Spring2016);
    Character Response
  • 🧂
  • Salt tolerance:
  • tolerates 2% salt; tolerates 18% salt; Grows optimally with 6-7% salt.
  • pH
  • Acidity tolerance:
  • tolerates pH 6.5-8.0; Grows optimally at pH 7.5.
  • 🌡
  • Temperature tolerance:
  • grows at 20℃; grows at 40℃; Grows optimally at 28℃.
  • Substrates assimilated or utilised:
  • N-acetylglucosamine; glucose; mannose; xylose; NH4+ consumed;

  • SPECIAL FEATURES (Spring2016);
    Character Response
  • Metabolites produced:
  • acetate; lactate (trace); ethanol;
  • Nitrate:
  • not reduced
  • Nitrite:
  • not reduced

  • RESPONSE TO ANTIBIOTICS (Spring2016);
    Class Active Resistant
  • Penicillins:
  • ampicillin; carbenicillin; penicillin G;
  • Tetracyclines:
  • tetracycline;
  • Aminoglycosides:
  • gentamicin; kanamycin;
  • Heterocycles:
  • chloramphenicol;

  • Details


    GENERAL
    Lineage Physiology General Growth Tolerances Hydrol./digest./degr.
    Phylum:  Kiritimatiellaeota Class:  Kiritimatiellae Order:  Kiritimatiellales Family:  Kiritimatiellaceae Genus:  Kiritimatiella Gram stain:  neg O2 Relation.:  strictly anaerobic Spore:  No spore Motility:  Sessile Morphology:  Coccus
    Health:  Unknown
    Source:  the suboxic zone of a hypersaline microbial mat, Republic of Kiribati
    DNA G+C(%):  63.3
    Opt. T:  28℃
    Lower T(℃):  20(+)
    Mid T(℃):  40(+)
    NaCl 0.5-2%:  2(+)
    NaCl >6%:  18(+)
    Opt. pH:  7.5
    pH 6.0-8.0:  6.5-8.0(+)
    Urea:  neg Alginate:  neg Chitin:  neg

    SUBSTRATE ASSIMILATION & UTILISATION
    Monosaccharide util/assim Oligosaccharide util/assim Other carboh. util/assim Amino acid util/assim Organic acid util/assim
    L-Arabinose:  neg Fructose:  neg Fucose:  neg Galactose:  neg Glucose:  + Mannose:  + Rhamnose:  neg Ribose:  neg Xylose:  + Cellubiose:  neg Lactose:  neg Maltose:  neg Melibiose:  neg Sucrose:  neg Trehalose:  neg N_Acetyl_glucosamine:  + Ethanol:  neg Glycerol:  neg Mannitol:  neg Methanol:  neg Propanol:  neg Starch:  neg Ala:  neg Glu:  neg Ile:  neg Acetate:  neg Benzoate:  neg Butyrate:  neg Citrate:  neg Fumarate:  neg DL-Lactate:  neg L-Malate:  neg Phenylpropionate:  neg Propionate:  neg Pyruvate:  neg Succinate:  neg

    ENZYME ACTIVITY
    Enzymes: General Enzymes: Carbohydrate Enzymes: Protein Enzymes: Arylamidases Enzymes: Esters/fats
    Oxidase:  neg Catalase:  neg

    ANTIBIOTICS ℞
    Penicillins & Penems (μg/mL) Cephalosporins (μg/mL) Aminoglycosides (μg/mL) Macrolides (μg/mL) Quinolones (μg/mL)
    ampicillin:  R(100; disc)
    carbenicil:  R(100; disc)
    penicillin_G:  R(100; disc)
    gentamicin:  R(100; disc)
    kanamycin:  R(1000; disc)
    Tetracyclines (μg/mL) Vancomycin Class (μg/mL) Polypep/ketides (μg/mL) Heterocycles (μg/mL) Other (μg/mL)
    tetracycline:  S(10; disc)
    chloramphenicol:  S(10; disc)

    References


    SPECIFIC REFERENCES FOR KIRITIMATIELLA GLYCOVORANS
  • Spring2016 - Characterization of the first cultured representative of Verrucomicrobia subdivision 5 indicates the proposal of a novel phylum.
  • ...............................
  • GUT MICROBIOME COMPILATIONS AND METASTUDIES FOR KIRITIMATIELLA GLYCOVORANS
  • New2022 - Collective effects of human genomic variation on microbiome function.
  • ...............................